Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis

被引:66
作者
Dumond, H
Presle, N
Pottie, P
Pacquelet, S
Terlain, B
Netter, P
Gepstein, A
Livne, E
Jouzeau, JY
机构
[1] Fac Med Vandoeuvre Nancy, Lab Pharmacol & Physiopathol Articulaires, CNRS, UMR 7561,UHP, F-54505 Vandoeuvre Les Nancy, France
[2] Technion Israel Inst Technol, IL-32000 Haifa, Israel
关键词
experimental osteoarthritis; rat model; interleukin-1; proteoglycans; matrix metalloproteinases;
D O I
10.1016/j.joca.2003.11.008
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Objectives: To characterize the molecular events underlying cartilage injury in the early phase of mono-iodoacetate-induced osteoarthritis (OA) in rats. Methods: Experimental osteoarthritis was induced by intra-articular injection of 0.03 mg mono-iodoacetate (MIA) in Wistar rats. Animals were killed 2, 5, 10, 15 and 20 days post-injection. Synovial tissue and standardized biopsies from different areas of knee cartilage were examined. Proteoglycan synthesis (S-35 incorporation) and gelatinase activities (zymography), semi-quantitative RT-PCR and immunohistochemistry for IL1beta, iNOS, COX2 and PPARgamma, were performed on these samples. Results: Changes in proteoglycan synthesis and gelatinase activities were time and site-dependent. Proteoglycan synthesis inhibition was maximal by day 2 while the highest gelatinase activities were observed at day 5. Central part of patella and posterior plateaus and condyles, i.e. the weight-bearing cartilage areas, were the most affected. 1L1beta and iNOS transcripts were induced early in cartilage at time of maximal proteoglycan synthesis inhibition, especially in weight-bearing areas. COX-2 was slightly up-regulated whereas PPARgamma gene expression remained unchanged. Gene expression profile in synovium paralleled that of cartilage, except for PPARgamma which was up-regulated at day 15 and 20. Immunostaining for IL1beta and iNOS showed that proteins were located in diseased cartilage areas at early stage of the experimental OA (day 2). At later time-points (day 20), IL1beta and iNOS were expressed in perilesional areas whereas immunostaining became below control level for COX-2 and PPARgamma. Conclusions: Time-dependent degradation of cartilage after injection of low dose of MIA (0.03mg) into rat knee joint can be related to early loss of proteoglycan anabolism, increased gelatinase activities and expression of IL1beta and downstream inflammatory genes. Increased susceptibility to MIA in weight-bearing areas of cartilage further indicate that MIA-induced experimental OA is a relevant model to study not only metabolical but also biomechanical aspects of human OA. (C) 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:284 / 295
页数:12
相关论文
共 39 条
[1]   Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage - Influence of nitric oxide [J].
Amin, AR ;
Attur, M ;
Patel, RN ;
Thakker, GD ;
Marshall, PJ ;
Rediske, J ;
Stuchin, SA ;
Patel, IR ;
Abramson, SB .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1231-1237
[2]   Susceptibility to physiological concentrations of IL-1β varies in cartilage at different anatomical locations on human osteoarthritic knee joints [J].
Barakat, AF ;
Elson, CJ ;
Westacott, CI .
OSTEOARTHRITIS AND CARTILAGE, 2002, 10 (04) :264-269
[3]  
BLANCO FJ, 1995, AM J PATHOL, V146, P75
[4]   Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) α and γ and retinoid Z receptor in cartilage -: PPARγ activation modulates the effects of interleukin-1β on rat chondrocytes [J].
Bordji, K ;
Grillasca, JP ;
Gouze, JN ;
Magdalou, J ;
Schohn, H ;
Keller, JM ;
Bianchi, A ;
Dauça, M ;
Netter, P ;
Terlain, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) :12243-12250
[5]   Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: Prolyl hydroxylase as a possible target [J].
Cao, M ;
WesterhausenLarson, A ;
Niyibizi, C ;
Kavalkovich, K ;
Georgescu, HI ;
Rizzo, CF ;
Hebda, PA ;
StefanovicRacic, M ;
Evans, CH .
BIOCHEMICAL JOURNAL, 1997, 324 :305-310
[6]   Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis - Suppression of collagenase-1 expression [J].
Caron, JP ;
Fernandes, JC ;
MartellPelletier, J ;
Tardif, G ;
Mineau, F ;
Geng, CS ;
Pelletier, JP .
ARTHRITIS AND RHEUMATISM, 1996, 39 (09) :1535-1544
[7]  
Clancy RM, 1998, ARTHRITIS RHEUM-US, V41, P1141, DOI 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO
[8]  
2-S
[9]  
DiBattista JA, 1997, J CELL BIOCHEM, V65, P408, DOI 10.1002/(SICI)1097-4644(19970601)65:3<408::AID-JCB10>3.0.CO
[10]  
2-B